KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Shares Outstanding (2016 - 2025)

Astrana Health's Shares Outstanding history spans 13 years, with the latest figure at $49.4 million for Q3 2025.

  • For Q3 2025, Shares Outstanding rose 3.36% year-over-year to $49.4 million; the TTM value through Sep 2025 reached $49.4 million, up 3.36%, while the annual FY2024 figure was $47.9 million, 2.32% up from the prior year.
  • Shares Outstanding for Q3 2025 was $49.4 million at Astrana Health, roughly flat from $49.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $49.4 million in Q3 2025 and bottomed at $42.6 million in Q1 2021.
  • The 5-year median for Shares Outstanding is $46.6 million (2022), against an average of $46.4 million.
  • The largest annual shift saw Shares Outstanding grew 21.86% in 2021 before it increased 0.58% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $44.6 million in 2021, then rose by 4.36% to $46.6 million in 2022, then grew by 0.58% to $46.8 million in 2023, then increased by 2.32% to $47.9 million in 2024, then rose by 3.03% to $49.4 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Shares Outstanding are $49.4 million (Q3 2025), $49.1 million (Q2 2025), and $49.0 million (Q1 2025).